Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

Pediatric Research

Volumn 23, Issue 2, 2004, Pages 99-109

  Sabchareon, Arunee ^a   Lang, Jean ^b   Chanthavanich, Pornthep ^a   Yoksan, Sutee ^a   Forrat, Remi ^b   Attanath, Phanorsi ^a   Sirivichayakul, Chukiate ^a   Pengsaa, Krisana ^a   Pojjaroen Anant, Chanathep ^a   Chambonneau, Laurent ^b   Saluzzo, Jean Francois ^b   Bhamarapravati, Natth ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SANOFI PASTEUR   (France)

Author keywords

Dengue vaccine; Immunogenicity; Pediatric trial; Safety

Indexed keywords

DENGUE VACCINE; LIVE VACCINE; RABIES VACCINE; TETRAVALENT LIVE ATTENUATED DENGUE VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ABDOMINAL PAIN; ANOREXIA; ARTHRALGIA; ARTICLE; BLOOD TOXICITY; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DENGUE; DENGUE LIKE FEVER; DENGUE VIRUS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EYE PAIN; FEMALE; FEVER; HEADACHE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGY; LIVER TOXICITY; MALE; METHODOLOGY; MYALGIA; NAUSEA; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; REFERENCE VALUE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; THAILAND; VACCINATION; VIREMIA;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION SCHEDULE; MALE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; THAILAND; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 10744224744     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1097/01.inf.0000109289.55856.27     Document Type: Article

References (25)

1. WHO. Dengue haemorrhagic fever: diagnosis, treatment and control. 2nd ed. Geneva: WHO, 1997.
2. Gubler D. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10: 100-3.
3. Halstead SB, Deen J. The future of dengue vaccines. Lancet 2002; 360: 1243-5.
4. Bhamarapravati N, Yoksan S, Chayaniyayothin T, Angsubpakorn S, Bunyaratvej A. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull World Health Organ 1987; 65: 189-95.
5. Bhamarapravati N, Yoksan S. Study of bivalent dengue vaccine in volunteers. Lancet 1989; 1: 1077.
6. Bhamarapravati N, Yoksan S. Live attenuated tetravalent dengue vaccine. Vaccine 2000; 18: 44-7.
7. Bhamarapravati N, Yoksan S. Live-attenuated tetravalent dengue vaccine. In: Gubler DJ, Kuno G, eds. Dengue and dengue hemorrhagic fever. Oxon, UK: CAB International, 1997: 367-77.
8. Kanesa-Thasan N, Sun W, Kim-Ahn G, et al. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 2001; 19: 3179-88.
9. Sabchareon A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio and multiple doses. Am J Trop Med Hyg 2002; 66: 264-72.
10. Yoksan S, Bhamarapravati N, Halstead SB. Dengue virus vaccine development: study on biological markers of uncloned dengue 1-4 viruses serially passaged in primary kidney cells. In: St George TD, Kay BH, Blok J, eds. Proceedings of the 4th Symposium on Arbovirus Research in Australia. Brisbane, Australia: CSIRO and Queensland Institute of Medical Research, 1986:35-8.
11. Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Lang J. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998; 17: 1001-7.
12. Jirakanjanakit N, Khin M. M, Yoksan S, Bhamarapravati N. The use of Toxorhynchites splendens for identification and quantification of serotypes contained in the tetravalent live attenuated dengue vaccine. Vaccine 1998; 17: 597-601.
13. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30: 545-51.
14. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958; 7: 561-73.
15. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967; 99: 285-90.
16. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176: 322-30.
17. Smith JS, Yager PA, Bear GM. A rapid tissue culture test for determining rabies-neutralizing antibodies. WHO Monogr Ser 1973; 23: 354-7.
18. WHO Expert Committee on Rabies. Eighth Report. WHO Technical Report Ser 824. Geneva: WHO, 1992: 21-2.
19. Kuo CH, Tai DI, Chang-Chien CS, Lan CK, Chiou SS, Liaw YF. Liver biochemical tests and dengue fever. Am J Trop Med Hyg 1992; 47: 265-70.
20. Rosen L, Khin MM, Drouet MT. Recovery of virus from the liver of children with fatal dengue: reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res Virol 1989; 140: 351-60.
21. Rosen L, Drouet MT, Deubel V. Detection of dengue virus RNA by transverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am J Trop Med Hyg 1999; 61: 720-4.
22. Halstead SB. Dengue: hematologic aspects. Semin Hematol 1982; 19: 116-31.
23. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994; 19: 500-12.
24. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of DHF in infants. Am J Trop Med Hyg 1988; 38: 411-19.
25. Ministry of Public Health (Thailand). Dengue haemorrhagic fever. In: Annual epidemiological surveillance report 2000. Bangkok: Express Transportation organization of Thailand, 2000: 101-5.